Holen Sie sich die Stockscreener-App
9.99
2.15%
0.21
Schlusskurs vom Vortag:
$9.78
Offen:
$9.68
24-Stunden-Volumen:
599.91K
Relative Volume:
0.63
Marktkapitalisierung:
$761.64M
Einnahmen:
$54.55M
Nettoeinkommen (Verlust:
$-193.57M
KGV:
-3.4567
EPS:
-2.89
Netto-Cashflow:
$-181.86M
1W Leistung:
+5.60%
1M Leistung:
-12.83%
6M Leistung:
-54.69%
1J Leistung:
-37.99%
1-Tages-Spanne:
$9.51
$10.10
1-Wochen-Bereich:
$9.25
$10.14
52-Wochen-Spanne:
$8.18
$29.56
Nurix Therapeutics Inc Stock (NRIX) Company Profile
Firmenname
Nurix Therapeutics Inc
Sektor
Branche
Telefon
(415) 660-5320
Adresse
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
Vergleichen Sie NRIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NRIX
Nurix Therapeutics Inc
|
9.99 | 721.19M | 54.55M | -193.57M | -181.86M | -2.89 |
|
ONC
Beigene Ltd Adr
|
238.76 | 24.41B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.03 | 111.55B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.2548 | 42.47M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
596.85 | 63.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
72.69 | 5.92B | 0 | -153.72M | -103.81M | -2.00 |
Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-17 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-12-10 | Eingeleitet | BTIG Research | Buy |
| 2024-12-06 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-10-11 | Eingeleitet | Jefferies | Buy |
| 2024-09-06 | Fortgesetzt | Robert W. Baird | Outperform |
| 2024-07-31 | Eingeleitet | Truist | Buy |
| 2023-06-26 | Fortgesetzt | Oppenheimer | Outperform |
| 2023-03-09 | Eingeleitet | Barclays | Overweight |
| 2023-02-28 | Eingeleitet | Oppenheimer | Outperform |
| 2022-10-11 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-05-31 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-12-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-14 | Eingeleitet | SVB Leerink | Outperform |
| 2021-06-04 | Fortgesetzt | Robert W. Baird | Outperform |
| 2021-04-30 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-04-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-04-14 | Eingeleitet | Berenberg | Buy |
| 2020-11-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-18 | Eingeleitet | JP Morgan | Overweight |
| 2020-08-18 | Eingeleitet | Needham | Buy |
| 2020-08-18 | Eingeleitet | Piper Sandler | Overweight |
| 2020-08-18 | Eingeleitet | Stifel | Buy |
Alle ansehen
Nurix Therapeutics Inc Aktie (NRIX) Neueste Nachrichten
Deutsche Bank AG Sells 323,485 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Holdings Raised by Soleus Capital Management L.P. - MarketBeat
97,889 Shares in Nurix Therapeutics, Inc. (NASDAQ:NRIX) Purchased by Velan Capital Investment Management LP - MarketBeat
Vestal Point Capital LP Buys 60,000 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Northern Trust Corp Grows Stock Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Jacobs Levy Equity Management Inc. Buys Shares of 229,369 Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Point72 Asset Management L.P. Makes New $16.45 Million Investment in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics Holds 2025 Annual Stockholders Meeting - TipRanks
Nurix Therapeutics reports stockholder voting results - Investing.com
Ensign Peak Advisors Inc Acquires 194,673 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) is Patient Square Capital LP's 6th Largest Position - MarketBeat
Parkman Healthcare Partners LLC Has $10.03 Million Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Cubist Systematic Strategies LLC Acquires Shares of 124,025 Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Bought by Integral Health Asset Management LLC - MarketBeat
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listin - GuruFocus
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com
Nurix Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference - TradingView
Nurix Therapeutics Announces Presentations of Clinical Data at t - GuruFocus
Nurix Therapeutics Announces Presentations of Clinical Data at the 30th European Hematology Association Congress and the 18th International Conference on Malignant Lymphoma - The Manila Times
Nurix Therapeutics to Present Phase 1a/b Clinical Trial Data on Bexobrutideg (NX-5948) for CLL and Waldenström Macroglobulinemia at EHA 2025 and 18-ICML Conferences - Nasdaq
Breakthrough Blood Cancer Treatment: Nurix's BTK Degrader Shows Promising Clinical Results in CLL Patients - Stock Titan
Where are the Opportunities in (NRIX) - news.stocktradersdaily.com
Why Nurix Therapeutics (NRIX) Is Among the Best Low Priced Biotech Stocks to Buy Now - Insider Monkey
10 Best Low Priced Biotech Stocks to Buy Now - Insider Monkey
Shareholders Will Probably Hold Off On Increasing Nurix Therapeutics, Inc.'s (NASDAQ:NRIX) CEO Compensation For The Time Being - simplywall.st
Voya Investment Management LLC Acquires 34,811 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
135,903 Shares in Nurix Therapeutics, Inc. (NASDAQ:NRIX) Purchased by First Trust Advisors LP - MarketBeat
Raymond James Financial Inc. Takes $1.03 Million Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Deep Track Capital LP Sells 868,104 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Invesco Ltd. Decreases Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Boxer Capital Management LLC Makes New Investment in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Sold by JPMorgan Chase & Co. - MarketBeat
RA Capital Management L.P. Acquires Shares of 1,333,333 Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Sold by Price T Rowe Associates Inc. MD - MarketBeat
Needham & Company LLC Reaffirms "Buy" Rating for Nurix Therapeutics (NASDAQ:NRIX) - MarketBeat
Darwin Global Management Ltd. Invests $3.08 Million in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Schonfeld Strategic Advisors LLC Boosts Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
Lord Abbett & CO. LLC Boosts Stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX) - MarketBeat
(NRIX) Trading Signals - news.stocktradersdaily.com
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Sold by T. Rowe Price Investment Management Inc. - MarketBeat
Finanzdaten der Nurix Therapeutics Inc-Aktie (NRIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.60%
6.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):